Compass Therapeutics shares rise 10.30% intraday after presenting at 44th Annual J.P. Morgan Healthcare Conference.

Compass Therapeutics surged 10.30% intraday following its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. The company’s participation in the high-profile event, led by an analyst from J.P. Morgan’s Healthcare Investment Banking Group, likely heightened investor interest in its pipeline or strategic updates. Such presentations often signal credibility and growth potential, aligning with the stock’s sharp intraday rally as traders anticipated positive momentum from the exposure.